2026-10-19 11:40:00 UTC#480079newconfirmednews
Cochlear Limited stock news
Cochlear Limited stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-19 03:42:00 UTC#478271newconfirmedanalysis
UBS warns of growing risks to Cochlear's fiscal 2028 earnings recovery due to Advanced Bionics competition
dow_jonesimportance 0.40trust 0.70Cochlear Limited -0.30UBS Group AG -0.20Advanced Bionics +0.30+2 entities
2026-10-15 04:01:00 UTC#463021duplicateconfirmedanalysis
UBS cuts Cochlear price target to A$135.00, citing growth headwinds and competitive pressure
dow_jonesimportance 0.40trust 0.80Cochlear Limited -0.40UBS Group AG -0.20Sonova Holding AG -0.20+1 entities
2026-10-14 23:01:00 UTC#462254newconfirmednews
UBS cuts Cochlear price target 10% to A$135.00 per share
2026-10-14 05:59:00 UTC#456792updateconfirmedanalysis
Jefferies: Sonova's new Integro CI processor unlikely to cause rapid market share losses for Cochlear
dow_jonesimportance 0.40trust 0.70Cochlear Limited +0.10Sonova Holding AG +0.30Advanced Bionics -0.20+2 entities
2026-09-28 23:17:49 UTC#380810duplicateconfirmednews
Cochlear to defend shareholder class action regarding FY26 profit forecast
2026-09-28 22:53:00 UTC#380736duplicateconfirmednews
Cochlear to Defend Against Shareholder Class Action Over FY26 Profit Forecast Downgrade
2026-09-28 22:25:39 UTC#380654newconfirmednews
Cochlear faces class action lawsuit in Victoria Supreme Court over FY26 profit forecast
2026-08-20 00:25:00 UTC#198108newconfirmednews
Morgans Raises Cochlear Limited Price Target 29% to A$138.42
2026-08-19 04:00:00 UTC#192992newconfirmednews
UBS raises Cochlear Limited price target by 42% to A$150.00 per share
2026-08-18 23:38:00 UTC#192351duplicateconfirmednews
Nikkei futures drop 1535 points on US bond rout; Jefferies warns Cochlear faces US payer constraints
dow_jonesimportance 0.40trust 0.80Nikkei 225 -0.50Cochlear Limited -0.40Jefferies Financial Group Inc. -0.30+2 entities
2026-08-18 22:31:00 UTC#192116updateconfirmedanalysis
Jefferies warns U.S. payer constraints and prior authorization rejections limit Cochlear growth
dow_jonesimportance 0.40trust 0.70Cochlear Limited -0.30Jefferies Financial Group Inc. -0.20United States of America -0.20
2026-08-18 21:29:00 UTC#191857newconfirmednews
Jefferies raises Cochlear Limited price target by 13% to A$144.75 per share
2026-08-18 16:33:00 UTC#190808newconfirmednews
WSJ Market Talk: Health Care Sector Roundup Featuring Ipca Laboratories and Cochlear
2026-08-18 03:51:47 UTC#187609duplicateconfirmednews
Cochlear Limited FY26 Revenue AUD 2.3B, Net Profit AUD 322M; FY27 Profit Guidance AUD 330M-350M
2026-08-18 02:26:00 UTC#187487updateconfirmednews
Cochlear CEO Dig Howitt says FY27 guidance is conservative to avoid repeat of previous outlook downgrades
2026-08-18 00:34:00 UTC#187287newconfirmedanalysis
Cochlear FY 2027 profit growth guidance driven by cost cuts rather than sales, Jarden analysts say
2026-08-18 00:24:00 UTC#187270updateconfirmedanalysis
RBC says Cochlear's FY 2026 revenue mix beats expectations despite acoustics miss
2026-08-17 23:49:00 UTC#187207newreportednews
ASX 200 set for decline as Trump threatens Oman; BHP profit rises, CSL posts loss, Brookfield bids for Reliance
dow_jonesimportance 0.60trust 0.80Donald Trump -0.30BHP Group Limited +0.40Cochlear Limited -0.50+2 entities
2026-08-17 23:12:00 UTC#187103duplicateconfirmednews